Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyloxy)ethyl)pyridine 1-oxide
2. Chf6001
3. Tanimilast
4. Tranimilast
1. Tanimilast
2. Tranimilast
3. 1239278-59-1
4. Chf6001
5. Tranimilast [usan]
6. J3.309.618f
7. Tanimilast [inn]
8. Unii-0984eu6e2f
9. [(1s)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxidopyridin-1-ium-4-yl)ethyl] 3-(cyclopropylmethoxy)-4-(methanesulfonamido)benzoate
10. 0984eu6e2f
11. 3,5-dichloro-4-((2s)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)-4-methanesulfonamidobenzoyloxy)ethyl)pyridin-1-ium-1-olate
12. 3,5-dichloro-4-[(2s)-2-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-[3-(cyclopropylmethoxy)-4-methanesulfonamidobenzoyloxy]ethyl]pyridin-1-ium-1-olate
13. Chembl3113974
14. Schembl12096092
15. Glxc-10137
16. Bdbm50495704
17. Who 11075
18. Db12800
19. Da-67921
20. Hy-19929
21. Cs-0016928
22. Ns00073468
23. Q27236468
24. (s)-3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)- 4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)- 4-(methylsulfonamido)benzoyloxy)ethyl)pyridine-1-oxide
25. (s)-3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyloxy)ethyl)pyridine 1-oxide
26. 2.3,5-dichloro-4-[(2s)-2-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-([3-(cyclopropylmethoxy)-4-(methanesulfonamido)benzoyl]oxy}ethyl]pyridine 1-oxide
27. 3-cyclopropylmethoxy-4[(methylsulfonyl)-amino]-1-(s)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxido-4-pyridinyl)-benzoic Acid Ethylester
28. Benzoic Acid, 3-(cyclopropylmethoxy)-4-((methylsulfonyl)amino)-, (1s)-1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3,5-dichloro-1-oxido-4-pyridinyl)ethyl Ester
| Molecular Weight | 687.5 g/mol |
|---|---|
| Molecular Formula | C30H30Cl2F2N2O8S |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 16 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 134 |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 1070 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
51
PharmaCompass offers a list of Tanimilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tanimilast manufacturer or Tanimilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tanimilast manufacturer or Tanimilast supplier.
PharmaCompass also assists you with knowing the Tanimilast API Price utilized in the formulation of products. Tanimilast API Price is not always fixed or binding as the Tanimilast Price is obtained through a variety of data sources. The Tanimilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tanimilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tanimilast, including repackagers and relabelers. The FDA regulates Tanimilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tanimilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tanimilast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tanimilast supplier is an individual or a company that provides Tanimilast active pharmaceutical ingredient (API) or Tanimilast finished formulations upon request. The Tanimilast suppliers may include Tanimilast API manufacturers, exporters, distributors and traders.
click here to find a list of Tanimilast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tanimilast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tanimilast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tanimilast GMP manufacturer or Tanimilast GMP API supplier for your needs.
A Tanimilast CoA (Certificate of Analysis) is a formal document that attests to Tanimilast's compliance with Tanimilast specifications and serves as a tool for batch-level quality control.
Tanimilast CoA mostly includes findings from lab analyses of a specific batch. For each Tanimilast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tanimilast may be tested according to a variety of international standards, such as European Pharmacopoeia (Tanimilast EP), Tanimilast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tanimilast USP).
